<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38435484</PMID><DateRevised><Year>2024</Year><Month>03</Month><Day>05</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2473-974X</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Season>Jan-Mar</Season></PubDate></JournalIssue><Title>OTO open</Title><ISOAbbreviation>OTO Open</ISOAbbreviation></Journal><ArticleTitle>Upper Respiratory Symptoms as Long COVID: Insight from a Multicenter Cohort Study.</ArticleTitle><Pagination><StartPage>e120</StartPage><MedlinePgn>e120</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e120</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/oto2.120</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">This study aimed to investigate the clinical features of long COVID cases presenting with upper respiratory symptoms, a topic not yet fully elucidated.</AbstractText><AbstractText Label="STUDY DESIGN" NlmCategory="UNASSIGNED">Prospective cohort study.</AbstractText><AbstractText Label="SETTING" NlmCategory="UNASSIGNED">A multicenter study involving 26 medical facilities in Japan.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Inclusion criteria were patients aged &#x2265;18 years old with a confirmed COVID-19 diagnosis via severe acute respiratory syndrome coronavirus 2 polymerase chain reaction or antigen testing, who were hospitalized at the participating medical facilities. Analyzing clinical information and patient-reported outcomes from 1009 patients were analyzed. The outcome measured the degree of initial symptoms for taste or olfactory disorders and assessed the likelihood of these symptoms persisting as long COVID, as well as the impact on quality of life if the upper respiratory symptoms persisted as long COVID.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Patients with high albumin, low C-reactive protein, and low lactate dehydrogenase in laboratory tests tended to experience taste or olfactory disorders as part of long COVID. Those with severe initial symptoms had a higher risk of experiencing residual symptoms at 3 months, with an odds ratio of 2.933 (95% confidence interval [CI], 1.282-6.526) for taste disorders and 3.534 (95% CI, 1.382-9.009) for olfactory disorders. Presence of upper respiratory symptoms consistently resulted in lower quality of life scores.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">The findings from this cohort study suggest that severe taste or olfactory disorders as early COVID-19 symptoms correlate with an increased likelihood of persistent symptoms in those disorders as long COVID.</AbstractText><CopyrightInformation>&#xa9; 2024 The Authors. OTO Open published by Wiley Periodicals LLC on behalf of American Academy of Otolaryngology&#x2013;Head and Neck Surgery Foundation.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Okada</LastName><ForeName>Masahiko</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Pulmonary Medicine Keio University School of Medicine Tokyo Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishida</LastName><ForeName>Noriyuki</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Biostatistics Unit, Clinical and Translational Research Center Keio University Hospital Tokyo Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kanzaki</LastName><ForeName>Sho</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology-Head and Neck Surgery Keio University Tokyo Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Auditory Disorders, National Institute of Sensory Organs National Hospital Organization Tokyo Medical Center Tokyo Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kawada</LastName><ForeName>Ichiro</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-8536-0018</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Division of Pulmonary Medicine Keio University School of Medicine Tokyo Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Center Keio University Yokohama Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagashima</LastName><ForeName>Kengo</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Biostatistics Unit, Clinical and Translational Research Center Keio University Hospital Tokyo Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Terai</LastName><ForeName>Hideki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Pulmonary Medicine Keio University School of Medicine Tokyo Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Keio Cancer Center Keio University School of Medicine Tokyo Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hiruma</LastName><ForeName>Gaku</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Biostatistics Unit, Clinical and Translational Research Center Keio University Hospital Tokyo Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Namkoong</LastName><ForeName>Ho</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Pulmonary Medicine Keio University School of Medicine Tokyo Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases Keio University School of Medicine Tokyo Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asakura</LastName><ForeName>Takanori</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Pulmonary Medicine Keio University School of Medicine Tokyo Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Respiratory Medicine Kitasato University Kitasato Institute Hospital Tokyo Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masaki</LastName><ForeName>Katsunori</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Pulmonary Medicine Keio University School of Medicine Tokyo Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ohgino</LastName><ForeName>Keiko</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Pulmonary Medicine Keio University School of Medicine Tokyo Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miyata</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Pulmonary Medicine Keio University School of Medicine Tokyo Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chubachi</LastName><ForeName>Shotaro</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Pulmonary Medicine Keio University School of Medicine Tokyo Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kodama</LastName><ForeName>Nobuhiro</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of General Internal Medicine Fukuoka Tokushukai Hospital Fukuoka Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maeda</LastName><ForeName>Shunsuke</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of General Internal Medicine Fukuoka Tokushukai Hospital Fukuoka Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sakamoto</LastName><ForeName>Satoshi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Respirology National Hospital Organization Kyushu Medical Center Fukuoka Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okamoto</LastName><ForeName>Masaki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Respirology National Hospital Organization Kyushu Medical Center Fukuoka Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagasaki</LastName><ForeName>Yoji</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Infectious Disease and Clinical Research Center National Hospital Organization Kyushu Medical Center Fukuoka Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Umeda</LastName><ForeName>Akira</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of General Medicine, School of Medicine, IUHW Shioya Hospital International University of Health and Welfare (IUHW) Tochigi Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miyagawa</LastName><ForeName>Kazuya</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pharmacology International University of Health and Welfare Tochigi Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shimada</LastName><ForeName>Hisato</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine International University of Health and Welfare Shioya Hospital Tochigi Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Minami</LastName><ForeName>Kazuhiro</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine Saitama Medical Center Saitama Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hagiwara</LastName><ForeName>Rie</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine Saitama Medical Center Saitama Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishii</LastName><ForeName>Makoto</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine Nagoya University Graduate School of Medicine Nagoya Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sato</LastName><ForeName>Yasunori</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Preventive Medicine and Public Health Keio University School of Medicine Tokyo Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fukunaga</LastName><ForeName>Koichi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Pulmonary Medicine Keio University School of Medicine Tokyo Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>OTO Open</MedlineTA><NlmUniqueID>101717942</NlmUniqueID><ISSNLinking>2473-974X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID&#x2010;19</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">olfactory disorder</Keyword><Keyword MajorTopicYN="N">taste disorder</Keyword><Keyword MajorTopicYN="N">upper respiratory symptoms</Keyword></KeywordList><CoiStatement>None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>4</Day><Hour>5</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38435484</ArticleId><ArticleId IdType="pmc">PMC10909391</ArticleId><ArticleId IdType="doi">10.1002/oto2.120</ArticleId><ArticleId IdType="pii">OTO2120</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Li X, Cui W, Zhang F. Who was the first doctor to report the COVID&#x2010;19 outbreak in Wuhan, China? J Nucl Med. 2020;61:782&#x2010;783.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7262218</ArticleId><ArticleId IdType="pubmed">32303602</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence . COVID&#x2010;19 Rapid Guideline: Managing the Long&#x2010;Term Effects of COVID&#x2010;19. National Institute for Health and Care Excellence (NICE); 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21:133&#x2010;146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F, et al. Persistent symptoms in patients after acute COVID&#x2010;19. JAMA. 2020;324:603&#x2010;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan CH, Faraji F, Prajapati DP, Boone CE, DeConde AS. Association of chemosensory dysfunction and COVID&#x2010;19 in patients presenting with influenza&#x2010;like symptoms. Int Forum Allergy Rhinol. 2020;10:806&#x2010;813.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7262089</ArticleId><ArticleId IdType="pubmed">32279441</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira LA, Salzano G, Deiana G, De Riu G. Anosmia and ageusia: common findings in COVID&#x2010;19 patients. Laryngoscope. 2020;130:1787.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7228304</ArticleId><ArticleId IdType="pubmed">32237238</ArticleId></ArticleIdList></Reference><Reference><Citation>Giacomelli A, Pezzati L, Conti F, et al. Self&#x2010;reported olfactory and taste disorders in patients with severe acute respiratory coronavirus 2 infection: a cross&#x2010;sectional study. Clin Infect Dis. 2020;71:889&#x2010;890.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7184514</ArticleId><ArticleId IdType="pubmed">32215618</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu C, Cui C, Hautefort C, et al. Olfactory and gustatory dysfunction as an early identifier of COVID&#x2010;19 in adults and children: an international multicenter study. Otolaryngol Head Neck Surg. 2020;163:714&#x2010;721.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7298561</ArticleId><ArticleId IdType="pubmed">32539586</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T, Hittle M, Goodman SN. Assessment of the frequency and variety of persistent symptoms among patients with COVID&#x2010;19: a systematic review. JAMA Netw Open. 2021;4:e2111417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendon&#xe7;a CV, Mendes Neto JA, Suzuki FA, Orth MS, Machado Neto H, Nacif SR. Olfactory dysfunction in COVID&#x2010;19: a marker of good prognosis? Braz J Otorhinolaryngol. 2022;88:439&#x2010;444.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7831803</ArticleId><ArticleId IdType="pubmed">33441276</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakagawara K, Chubachi S, Namkoong H, et al. Impact of upper and lower respiratory symptoms on COVID&#x2010;19 outcomes: a multicenter retrospective cohort study. Respir Res. 2022;23:315.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9665023</ArticleId><ArticleId IdType="pubmed">36380316</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad MS, Shaik RA, Ahmad RK, et al. &#x201c;LONG COVID&#x201d;: an insight. Eur Rev Med Pharmacol Sci. 2021;25:5561&#x2010;5577.</Citation><ArticleIdList><ArticleId IdType="pubmed">34533807</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo&#x2010;Rizzo P, Borsetto D, Fabbris C, et al. Evolution of altered sense of smell or taste in patients with mildly symptomatic COVID&#x2010;19. JAMA Otolaryngol Head Neck Surg. 2020;146:729&#x2010;732.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7333173</ArticleId><ArticleId IdType="pubmed">32614442</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo&#x2010;Rizzo P, Hummel T, Hopkins C, et al. Comprehensive chemosensory psychophysical evaluation of self&#x2010;reported gustatory dysfunction in patients with long&#x2010;term COVID&#x2010;19: a cross&#x2010;sectional study. JAMA Otolaryngol Head Neck Surg. 2022;148:281&#x2010;282.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8739827</ArticleId><ArticleId IdType="pubmed">34989788</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo&#x2010;Rizzo P, Fabbris C, Polesel J, et al. Two&#x2010;year prevalence and recovery rate of altered sense of smell or taste in patients with mildly symptomatic COVID&#x2010;19. JAMA Otolaryngol Head Neck Surg. 2022;148:889&#x2010;891.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9353700</ArticleId><ArticleId IdType="pubmed">35925596</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelin D, Margalit I, Nehme M, et al. Patterns of long COVID symptoms: a multi&#x2010;center cross sectional study. J Clin Med. 2022;11:898.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8875229</ArticleId><ArticleId IdType="pubmed">35207171</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan BKJ, Han R, Zhao JJ, et al. Prognosis and persistence of smell and taste dysfunction in patients with covid&#x2010;19: meta&#x2010;analysis with parametric cure modelling of recovery curves. BMJ. 2022;378:e069503.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9326326</ArticleId><ArticleId IdType="pubmed">35896188</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreli F, Gaino F, Russo E, et al. Long&#x2010;standing gustatory and olfactory dysfunction in COVID&#x2010;19 patients: a prospective study. Eur Arch Otrhinolaryngol. 2022;279:4633&#x2010;4640.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9244308</ArticleId><ArticleId IdType="pubmed">35767055</ArticleId></ArticleIdList></Reference><Reference><Citation>Chudzik M, Babicki M, Mastalerz&#x2010;Migas A, Kapusta J. Persisting smell and taste disorders in patients who recovered from SARS&#x2010;CoV&#x2010;2 virus infection&#x2010;data from the Polish PoLoCOV&#x2010;CVD study. Viruses. 2022;14:1763.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9416276</ArticleId><ArticleId IdType="pubmed">36016385</ArticleId></ArticleIdList></Reference><Reference><Citation>Coelho DH, Reiter ER, Budd SG, Shin Y, Kons ZA, Costanzo RM. Predictors of smell recovery in a nationwide prospective cohort of patients with COVID&#x2010;19. Am J Otolaryngol. 2022;43:103239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8443532</ArticleId><ArticleId IdType="pubmed">34547716</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahrvini B, Prajapati DP, Said M, et al. Risk factors and characteristics associated with persistent smell loss in coronavirus disease 2019 (COVID&#x2010;19) patients. Int Forum Allergy Rhinol. 2021;11:1280&#x2010;1282.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8251222</ArticleId><ArticleId IdType="pubmed">33864717</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan BKJ, Han R, Zhao JJ, et al. Prognosis and persistence of smell and taste dysfunction in patients with covid&#x2010;19: meta&#x2010;analysis with parametric cure modelling of recovery curves. BMJ. 2022;378:e069503.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9326326</ArticleId><ArticleId IdType="pubmed">35896188</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakagawara K, Namkoong H, Terai H, et al. Comprehensive and long&#x2010;term surveys of COVID&#x2010;19 sequelae in Japan, an ambidirectional multicentre cohort study: study protocol. BMJ Open Respir Res. 2021;8:e001015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8628335</ArticleId><ArticleId IdType="pubmed">34836924</ArticleId></ArticleIdList></Reference><Reference><Citation>Terai H, Ishii M, Takemura R, et al. Comprehensive analysis of long COVID in a Japanese nationwide prospective cohort study. Respir investig. 2023;61:802&#x2010;814. 10.1016/j.resinv.2023.08.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resinv.2023.08.008</ArticleId><ArticleId IdType="pubmed">37783167</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaye R, Chang CWD, Kazahaya K, Brereton J, Denneny JC. COVID&#x2010;19 anosmia reporting tool: initial findings. Otolaryngol Head Neck Surg. 2020;163:132&#x2010;134.</Citation><ArticleIdList><ArticleId IdType="pubmed">32340555</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiroiwa T, Ikeda S, Noto S, et al. Comparison of value set based on DCE and/or TTO data: scoring for EQ&#x2010;5D&#x2010;5L health states in Japan. Value Health. 2016;19:648&#x2010;654.</Citation><ArticleIdList><ArticleId IdType="pubmed">27565282</ArticleId></ArticleIdList></Reference><Reference><Citation>Ware J, Kosinski M, Dewey J, et al. How to Score and Interpret Single&#x2010;Item Health Status Measures: A Manual for Users of the SF&#x2010;8TM Health Survey. Quality Metrics; 2001.</Citation></Reference><Reference><Citation>Ministry of Health, Labour and Welfare . Clinical Management of Patients with COVID&#x2010;19: A Guide for Frontline Healthcare Workers. version 242 2.1. Ministry of Health, Labour and Welfare; 2020.</Citation></Reference><Reference><Citation>WHO BMI classification. Accessed July 29, 2023. https://www.cdc.gov/obesity/basics/adult-defining.html#:~:text=Adult%20Body%20Mass%20Index&amp;text=If%20your%20BMI%20is%20less,falls%20within%20the%20obesity%20range
</Citation></Reference><Reference><Citation>Paderno A, Mattavelli D, Rampinelli V, et al. Olfactory and gustatory outcomes in COVID&#x2010;19: a prospective evaluation in nonhospitalized subjects. Otolaryngol Head Neck Surg. 2020;163:1144&#x2010;1149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7331108</ArticleId><ArticleId IdType="pubmed">32600175</ArticleId></ArticleIdList></Reference><Reference><Citation>Rass V, Beer R, Schiefecker AJ, et al. Neurological outcomes 1 year after COVID&#x2010;19 diagnosis: a prospective longitudinal cohort study. Eur J Neurol. 2022;29:1685&#x2010;1696.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9111823</ArticleId><ArticleId IdType="pubmed">35239247</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiter ER, Coelho DH, Kons ZA, Costanzo RM. Subjective smell and taste changes during the COVID&#x2010;19 pandemic: Short term recovery. Am J Otolaryngol. 2020;41:102639.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7341046</ArticleId><ArticleId IdType="pubmed">32682192</ArticleId></ArticleIdList></Reference><Reference><Citation>Renaud M, Thibault C, Le Normand F, et al. Clinical outcomes for patients with anosmia 1 year after COVID&#x2010;19 diagnosis. JAMA Netw Open. 2021;4:e2115352.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8226421</ArticleId><ArticleId IdType="pubmed">34165581</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendes Paranhos AC, Nazareth Dias &#xc1;R, Machado da Silva LC, et al. Sociodemographic characteristics and comorbidities of patients with long COVID and persistent olfactory dysfunction. JAMA Netw Open. 2022;5:e2230637.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9459661</ArticleId><ArticleId IdType="pubmed">36074464</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen A, Agarwal A, Ravindran N, To C, Zhang T, Thuluvath PJ. Are gastrointestinal symptoms specific for coronavirus 2019 infection? A prospective case&#x2010;control study from the United States. Gastroenterology. 2020;159:1161&#x2010;1163.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7229473</ArticleId><ArticleId IdType="pubmed">32422209</ArticleId></ArticleIdList></Reference><Reference><Citation>Yagi K, Asakura T, Terai H, et al. Clinical features of Japanese patients with gastrointestinal long&#x2010;COVID symptoms. JGH Open. 2023;7:998&#x2010;1002. 10.1002/jgh3.13006</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jgh3.13006</ArticleId><ArticleId IdType="pmc">PMC10757478</ArticleId><ArticleId IdType="pubmed">38162867</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Mak JWY, Su Q, et al. Gut microbiota dynamics in a prospective cohort of patients with post&#x2010;acute COVID&#x2010;19 syndrome. Gut. 2022;71:544&#x2010;552.</Citation><ArticleIdList><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Meringer H, Mehandru S. Gastrointestinal post&#x2010;acute COVID&#x2010;19 syndrome. Nat Rev Gastroenterol Hepatol. 2022;19:345&#x2010;346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8981882</ArticleId><ArticleId IdType="pubmed">35383321</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyama AK, Siegel DA, Oyegun E, Hampton W, Maddox N, Koumans EH. Symptoms reported with new onset of loss of taste or smell in individuals with and without SARS&#x2010;CoV&#x2010;2 infection. JAMA Otolaryngol Head Neck Surg. 2021;147:911&#x2010;914.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8414356</ArticleId><ArticleId IdType="pubmed">34473217</ArticleId></ArticleIdList></Reference><Reference><Citation>Allisan&#x2010;Arrighi AE, Rapoport SK, Laitman BM, et al. Long&#x2010;term upper aerodigestive sequelae as a result of infection with COVID&#x2010;19. Laryngoscope Investig Otolaryngol. 2022;7:476&#x2010;485.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9008172</ArticleId><ArticleId IdType="pubmed">35434347</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID. Nat Med. 2021;27:626&#x2010;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Otsuka Y, Tokumasu K, Nakano Y, et al. Clinical characteristics of Japanese patients who visited a COVID&#x2010;19 aftercare clinic for post&#x2010;acute sequelae of COVID&#x2010;19/long COVID. Cureus. 2021;13:e18568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8571943</ArticleId><ArticleId IdType="pubmed">34760415</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue S, Abe R, Tanaka Y, Kawaguchi M. Tracheal intubation by trainees does not alter the incidence or duration of postoperative sore throat and hoarseness: a teaching hospital&#x2010;based propensity score analysis. Br J Anaesth. 2015;115:463&#x2010;469.</Citation><ArticleIdList><ArticleId IdType="pubmed">26243647</ArticleId></ArticleIdList></Reference><Reference><Citation>Ya&#x11f;mur AR, Akbal &#xc7;ufal&#x131; &#x15e;, Aypak A, K&#xf6;ksal M, G&#xfc;ne&#x15f; YC, &#xd6;zcan KM. Correlation of olfactory dysfunction with lung involvement and severity of COVID&#x2010;19. Irish J Med Sci (1971). 2022;191:1843&#x2010;1848.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352757</ArticleId><ArticleId IdType="pubmed">34374938</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien JR, Chiesa&#x2010;Estomba CM, De Siati DR, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild&#x2010;to&#x2010;moderate forms of the coronavirus disease (COVID&#x2010;19): a multicenter European study. Eur Arch Otrhinolaryngol. 2020;277:2251&#x2010;2261.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7134551</ArticleId><ArticleId IdType="pubmed">32253535</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitcroft KL, Hummel T. Olfactory dysfunction in COVID&#x2010;19: diagnosis and management. JAMA. 2020;323:2512&#x2010;2514.</Citation><ArticleIdList><ArticleId IdType="pubmed">32432682</ArticleId></ArticleIdList></Reference><Reference><Citation>Coelho DH, Reiter ER, Budd SG, Shin Y, Kons ZA, Costanzo RM. Quality of life and safety impact of COVID&#x2010;19 associated smell and taste disturbances. Am J Otolaryngol. 2021;42:103001.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7983361</ArticleId><ArticleId IdType="pubmed">33773440</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>